Micro Developing Active

APOGEE CEO vende azioni dopo l'impennata del titolo

Punteggio
0,3
Velocità
▲ 0,0
Articoli
5
Fonti
2

Riepilogo

Un articolo appartiene a questa narrazione se discute della vendita di azioni da parte del CEO di Apogee Therapeutics a seguito di un significativo aumento del prezzo delle azioni.

Articoli Correlati

Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?

Yahoo Finance · Mar 30, 2026
Mixed

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Nasdaq · Mar 28, 2026
Bearish

Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's …

Nasdaq · Mar 26, 2026
Mixed

Fonti

Eos Energy Director Buys $100,000 in Stock -- What Investors … Nasdaq
Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the … Yahoo Finance
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in … Nasdaq
Bicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks … Nasdaq
Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% … Nasdaq

Cronologia

Ultimo aggiornamento Mar 26, 2026